Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like

Prostate

Volumn 72, Issue 13, 2012, Pages 1453-1463

  Vêncio, Eneida F ^a,b   Nelson, Angelique M ^c   Cavanaugh, Christopher ^c   Ware, Carol B ^c   Milller, Daniel G ^a   Garcia, Julio C O ^d   Vêncio, Ricardo Z N ^d   Loprieno, Michelle A ^a   Liu, Alvin Y ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

induced pluripotent stem cells; prostate cancer associated stromal cells; transcriptomes

Indexed keywords

CD133 ANTIGEN; LENTIVIRUS VECTOR; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR LIN28; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL ISOLATION; CELL SELECTION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; MICROARRAY ANALYSIS; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROSTATE CANCER ASSOCIATED STROMAL CELL; RNA ISOLATION; TRANSCRIPTOMICS; TRANSGENE;

EID: 84864875144     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22497     Document Type: Article

References (37)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S,. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131 (5): 861-872. (Pubitemid 350138099)
2. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Sluvkin II, Thomson JA,. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318 (5858): 1917-1920.
3. Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi K, Stewart R, Thomson JA, Slukvin II,. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011; 117 (14): e109-e119.
4. + prostate tumor-associated stromal cells involves potential organ-specific genes. BMC Cancer 2009; 9: 317.
5. Pascal LE, Ai J, Vêncio RZN, Vêncio EF, Zhou Y, Page LS, True LD, Wang Z, Liu AY,. Differential inductive signaling of prostate tumor-associated stromal cells compared to normal tissue stromal mesenchyme cells. Cancer Microenvironment 2011; 4 (1): 51-559.
6. hi prostate cancer-associated fibroblasts. Prostate 2009; 69 (9): 991-1000.
7. Goo YA, Liu AY, Ryu S, Shaffer SA, Malmström L, Page L, Nguyen LT, Doneanu CE, Goodlett DR,. Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics. Prostate 2009; 69 (1): 49-61.
8. Vêncio EF, Pascal LE, Page LS, Denyer G, Wang AJ, Ruohola-Baker H, Zhang S, Wang K, Galas DJ, Liu AY,. Embryonal carcinoma cell induction of miRNA and mRNA changes in co-cultured prostate stromal fibromuscular cells. J Cell Physiol 2010; 226 (6): 1479-1488.
9. Bonkhoff H, Remberger K,. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 1996; 28 (2): 98-106. (Pubitemid 26066247)
10. Liu AY, True LD,. Characterization of prostate cell types by CD cell surface molecules. Am J Pathol 2002; 160 (1): 37-43. (Pubitemid 34052263)
11. Liu AY, True LD, LaTray L, Nelson PS, Ellis WJ, Vessella RL, Lange PH, Hood L, van den Engh G,. Cell-cell interaction in prostate gene regulation and cytodifferentiation. Proc Natl Acad Sci USA 1997; 94 (20): 10705-10710. (Pubitemid 27430798)
12. Oudes AJ, Campbell DS, Sorensen CM, Walashek LS, True LD, Liu AY,. Transcriptomes of human prostate cells. BMC Genomics 2006; 7: 92.
13. Pascal LE, Vêncio RZN, Page LS, Liebeskind ES, Shadle CP, Troisch P, Marzolf B, True LD, Hood LE, Liu AY,. Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes. BMC Cancer 2009; 9: 452.
14. True LD, Zhang H, Ye M, Huang C, Nelson PS, von Haller PD, Tjoelker LW, Kim J, Qian W, Smith RD, Ellis WJ, Liebeskind ES, Liu AY,. CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker. Mod Pathol 2010; 23 (10): 1346-1356.
15. Ware CB, Nelson AM, Blau CA,. A comparison of NIH-approved human ESC lines. Stem Cells 2006; 24 (12): 2677-2684. (Pubitemid 46053005)
16. Damjanov I, Horvat B, Gibas Z,. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line. NCCIT. Lab Invest 1993; 68 (2): 220-232. (Pubitemid 23084295)
17. Liu AY, LaTray L, van den Engh G,. Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells. Prostate 2000; 44 (4): 303-312.
18. Goo YA, Goodlett DR, Pascal LE, Worthington KD, Vessella RL, True LD, Liu AY,. Stromal mesenchyme cell genes of the human prostate and bladder. BMC Urol 2005; 5: 17.
19. Pascal LE, Vêncio RZN, Goo YA, Page LS, Shadle CP, Liu AY,. Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells. Prostate 2009; 69 (12): 1353-1365.
20. Ibrahimi A, Vande Velde G, Reumers V, Toelen J, Thiry I, Vandeputte C, Vets S, Deroose C, Bormans G, Baekelandt V, Debyser Z, Gijsbers R,. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences. Hum Gene Ther 2009; 20 (8): 845-860.
21. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA,. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324 (5928): 797-801.
22. Klages N, Zufferey R, Trono D,. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther 2000; 2 (2): 170-176.
23. Salmon P, Trono D,. Production and titration of lentiviral vectors. Curr Protoc Hum Genet 2007; Chapter 12: Unit 12.10.
24. Pascal LE, Vêncio RZN, Vessella RL, Ware CB, Vêncio EF, Denyer G, Liu AY,. Lineage relationship of prostate cancer cell types based on gene expression. BMC Medical Genomics 2011; 4: 46.
25. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP,. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4 (2): 249-264.
26. Marzolf B, Deutsch EW, Moss P, Campbell D, Johnson MH, Galitski T,. SBEAMS-Microarray: Database software supporting genomic expression analyses for systems biology. BMC Bioinformatics 2006; 7: 286.
27. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA,. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA 2003; 100 (23): 13350-13355. (Pubitemid 37444745)
28. Pascal LE, Oudes AJ, Petersen TW, Goo YA, Walashek LS, True LD, Liu AY,. Molecular and cellular characterization of ABCG2 in the prostate. BMC Urol 2007; 7: 6.
29. Pascal LE, Deutsch EW, Campbell DS, Korb M, True LD, Liu AY,. The urologic epithelial stem cell database (UESC)-a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder. BMC Urol 2007; 7: 19.
30. Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY,. Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 2008; 9: 246.
31. Smith KP, Luong MX, Stein GS,. Pluripotency: Toward a gold standard for human ES and iPS cells. J Cell Physiol 2009; 220 (1): 21-29.
32. Taranger CK, Noer A, Sørensen AL, HÃ¥kelien A, Boquest AC, Collas P,. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 2005; 16 (12): 5719-5735. (Pubitemid 41752221)
33. Yan X, Qin H, Qu C, Tuan RS, Shi S, Huang GT,. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev 2010; 19 (4): 469-480.
34. Stadtfeld M, Hochedlinger K,. Induced pluripotency: History, mechanisms, and applications. Genes Dev 2010; 24 (20): 2239-2263.
35. Zhou T, Benda C, Duzinger S, Huang Y, Li X, Li Y, Guo X, Cao G, Chen S, Hao L, Chan Y, Ng K, Ho JC, Wieser M, Wu J, Redl H, Tse H, Grillari J, Grillari-Voglauer R, Pei D, Esteban MA,. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 2011; 22 (7): 1221-1228.
36. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, Wu JC,. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 2009; 106 (37): 15720-15725.
37. Solanki A, Lee KB,. A step closer to complete chemical reprogramming for generating iPS cells. Chembiochem 2010; 11 (6): 755-757.